Hemorrhagic Proctocolitis Clinical Trials

Find Hemorrhagic Proctocolitis Clinical Trials Near You

Impact of a Structured Therapeutic Education Session on the Practice of Adapted Physical Activity in Chronic Inflammatory Bowel Diseases

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test, Other
Study Type: Observational
SUMMARY

Chronic inflammatory bowel diseases (IBD; including Crohn's disease and ulcerative colitis) significantly impact patients' quality of life. Among non-pharmacological therapies, adapted physical activity (APA) has demonstrated its beneficial impact, particularly on fatigue, anxiety, digestive symptoms, and the overall quality of life of patients with IBD. The real-world implementation of APA remains insufficient, primarily due to limited patient adherence to this prescription. Patient therapeutic education (PTE) represents a potentially powerful lever for promoting engagement in APA by addressing barriers related to a lack of awareness (fear of symptom worsening) and lack of motivation. No dedicated study has specifically evaluated the effect of targeted PTE sessions on adherence to physical activity in IBD. The objective of the present feasibility study will be to determine whether a single therapeutic education session focused on the digestive and systemic benefits of APA has an impact on the rate of physical activity practice in the medium term among patients with IBD in clinical remission for at least 3 months.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 100
Healthy Volunteers: f
View:

• Confirmed diagnosis of Inflammatory Bowel Disease

• Crohn's disease in clinical remission (defined by a Harvey Bradshaw Index ≤ 5) or ulcerative colitis in clinical remission (defined by a Mayo score \< 3 and no subscore \> 1) for at least 3 months

• Social Security coverage

Locations
Other Locations
France
Service de Gastro-Entérologie, CHU Toulouse, Hôpital Rangueil, 1 avenue Jean Poulhès
RECRUITING
Toulouse
Contact Information
Primary
Cyrielle GILLETTA, MD
gilletta.c@chu-toulouse.fr
05 61 31 22 31
Time Frame
Start Date: 2026-02-10
Estimated Completion Date: 2029-02-10
Participants
Target number of participants: 71
Treatments
patients with chronic inflammatory bowel disease
patients with chronic inflammatory bowel disease in clinical remission
Sponsors
Leads: University Hospital, Toulouse

This content was sourced from clinicaltrials.gov